Straumann Holding AG (OTCMKTS:SAUHY) Sees Large Decrease in Short Interest

Posted by Tristan Rich on Aug 13th, 2026

Straumann Holding AG (OTCMKTS:SAUHY – Get Free Report) saw a significant drop in short interest in the month of July. As of July 31st, there was short interest totaling 5,152 shares, a drop of 77.6% from the July 15th total of 23,021 shares. Based on an average daily volume of 79,441 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.0% of the shares of the company are short sold.

Analyst Ratings Changes

A number of equities analysts recently issued reports on SAUHY shares. Barclays reissued an “overweight” rating on shares of Straumann in a report on Thursday, June 18th. Citigroup reissued a “sell” rating on shares of Straumann in a report on Thursday, July 9th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Straumann in a report on Tuesday, June 30th. Morgan Stanley reissued an “underweight” rating on shares of Straumann in a research note on Tuesday, June 30th. Finally, BMO Capital Markets initiated coverage on shares of Straumann in a research note on Wednesday, July 8th. They issued an “outperform” rating for the company. Three analysts have rated the stock with a Buy rating, two have given a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold”.

Get Our Latest Analysis on Straumann

Straumann Trading Down 0.9%

SAUHY stock traded down $0.11 during trading hours on Thursday, hitting $12.50. 6,124 shares of the stock traded hands, compared to its average volume of 137,005. The stock has a 50-day simple moving average of $12.54 and a 200 day simple moving average of $11.70. Straumann has a one year low of $9.44 and a one year high of $13.61.

Straumann Company Profile

(Get Free Report)

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.